Anixa Biosciences (ANIX) vs Cumberland Pharmaceuticals (CPIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Anixa Biosciences (ANIX) over the past year, gaining 93.5% versus a loss of 28.2%. Over five years, CPIX leads with a +151.5% price change compared with -32.8% for ANIX. Cumberland Pharmaceuticals is the larger company by market cap ($103.2 million vs $102.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIX | CPIX |
|---|---|---|
| Share price | $2.95 | $6.89 |
| Market cap | $102.55M | $103.23M |
| 1-day change | -2.32% | -3.50% |
| YTD return | -5.45% | +73.12% |
| 1-year return | -28.22% | +93.54% |
| 5-year return | -32.80% | +151.46% |
| Forward P/E | — | 49.21 |
| EPS (TTM) | $-0.32 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.46 | $9.28 |
| 52-week low | $2.32 | $1.85 |
| Distance from 52-week high | -45.97% | -25.75% |
| Average volume | 301.35K | 87.97K |
| Shares outstanding | 34.76M | 14.98M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPIX has outperformed ANIX by 121.8 percentage points over the past year.
ANIX vs CPIX FAQ
Which is bigger, Anixa Biosciences or Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $103.23M compared with $102.55M for Anixa Biosciences (ANIX).
Which stock has performed better over the past year, ANIX or CPIX?
CPIX returned +93.54% over the past 12 months, compared with -28.22% for ANIX (price return, excluding dividends). Past performance does not predict future results.
Are Anixa Biosciences and Cumberland Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.